ABSTRACT AIM To compare reduction in intraocular pressure (IOP) and gain in visual acuity (VA) following phacotrabeculectomy (PT) and phacoemulsification(phaco) in Tanzanian patients with primary open angle glaucoma(POAG). Setting CCBRT Hospital, Dar es Salaam, Tanzania. Design Within-person observational cohort study. Methods Within each patient, one eye had PT and the other phaco. Patients were followed for up to 5-1/2 years, and IOP and VA in each eye were assessed. For a small group of patients, two additional postoperative time points were compared. Results 52 patients (34 male) with a mean age of 70 years (SD 8 years) were enrolled in the study. For those with 250 days or more follow-up, both operations resulted in lower IOPs and improved VA (p<0.001). The average drop in IOP was 50% (95%CI 45% to 55%) for PT and 41% (95% CI 36% to 46%) for phaco. Mean IOP was lower in the PT group 12.9 mm Hg vs 16.8 mm Hg (p=0.004). Extended follow-up in nine patients showed a rise in IOP of 1.8 mm Hg for PT and 4.2 mm Hg for phaco eyes between first (mean, 337 days) and second (mean 1482 days) follow-up (p=0.18). Conclusion In this small study in African patients, PT resulted in lower IOPs than phacoemulsification alone but the difference between the procedures was relatively small. Phacoemulsification alone was effective in reducing IOP and improving VA for several years in this population. Given the relative simplicity of phacoemulsification, it is a therapeutic option worthy of consideration in some settings.
InTRoDuCTIon
More than 80% of the 285 million visually impaired individuals in the world live in low and middle-income countries, with 15% in Africa despite this continent having only 12% of the world's population. 1 Cataract and glaucoma are leading causes of blindness in Africa. [2] [3] [4] Since they are both age-related conditions, they often co-exist. 5 Both have surgical solutions, but debate continues with respect to the optimal management strategy. Trabeculectomy surgery for glaucoma is known to accelerate cataract. 6 After trabeculectomy, the risk of requiring cataract surgery is reported as between 20% and 52% up to 7 years postoperatively. However, cataract removal after trabeculectomy surgery increases the risk of trabeculectomy failure which can range from 10% to 61% within 3 years of cataract surgery. 6 Many patients in Africa are financially constrained and live in rural areas, rendering two operations unaffordable or impractical.
We recently undertook a randomised controlled trial to evaluate the efficacy of intraoperative beta radiation compared with the standard 5 fluorouracil (5FU) as an adjuvant therapy in primary open angle glaucoma (POAG) in Tanzanian patients undergoing phacotrabeculectomy (PT). The success rate in this phacotrabeculectomy trial (PTT), as measured by a continuing intraocular pressure (IOP) reduction (<16 mm Hg) at 1 year, was over 70%.
It has long been appreciated that cataract surgery alone lowers IOP. [7] [8] [9] There has been increasing debate as to whether cataract surgery alone may be an option for the management of glaucoma in some circumstances. then this may represent a better option for elderly Tanzanian patients than combined cataract and glaucoma surgery. Moreover, early visual rehabilitation in such patients may encourage them to return for follow-up should the need for trabeculectomy arise and encourage other patients with similar conditions to attend eye clinics and undergo surgery. This study compares IOP and visual acuity (VA) after combined PT or phacoemulsification alone in eyes with both glaucoma and cataract.
MeThoDS
We undertook an observational cohort study taking advantage of the PTT, to compare IOP reduction and VA improvement after PT and phacoemulsification surgeries. Details of the PTT are published elsewhere. 12 In summary, patients with primary open angle glaucoma and cataract fulfilling the inclusion criteria (table 2) were recruited in the PTT. For inclusion in this study, both eyes had to satisfy these inclusion criteria.
Following informed written consent, patients with bilateral POAG and cataract were enrolled in the PTT. Each enrolled patient underwent PT on the eye with better VA with random allocation to receive either adjunctive 5FU or beta radiation at the time of surgery. 12 In a number of patients enrolled in the trial, phacoemulsification with intraocular lens (IOL) implant alone was subsequently performed in the fellow eye. This report concerns those individuals who underwent PT in one eye and then phacoemulsification alone in the fellow eye. The primary outcome was IOP reduction from baseline. The secondary outcome was VA change from baseline. In the PTT, patients were reviewed on day 1, and then after 1, 3, 6 and 12 months. At every visit, unaided and pin hole VA were measured using a reduced logarithm of minimum angle of resolution Clinical science acuity chart (log MAR) by an optometrist who was trained to use the chart. The tumbling E chart (log MAR) was used for unlettered patients. Prior to phacoemulsification, surgery baseline logMAR acuities were recorded. If follow-up acuities were Snellen, these were converted to logMAR equivalents. For the purposes of analysis, count fingers vision at 1 m or less was recorded as 2.0, hand motions as 3.0 and perception of light as 4.0. The last review with the longest period of follow-up was taken. At a postoperative period of more than 3 years, an attempt was made to review all patients again. Nine patients attended for review creating a second follow-up time point. IOP was measured using a Goldmann tonometer which was calibrated and checked at the beginning of each clinic. For baseline IOP, the median of three read ings taken at different times of the day was taken. For follow-up of PTT, the same outcome was used. For the phaco-only eyes, a mean of two readings at separate times was used. Patients with increasing IOPs (>18) and/or glaucoma progression were started on appropriate antiglaucoma medication. Data were recorded on a pretested case report form and entered using Excel. Data were analysed using Stata V. 13 (www. stata. com). Paired t-tests were used to compare outcomes between eyes within-individual patients. Where small numbers were present the non-parametric Wilcoxon matched pairs signed-rank test was used. p values presented are two-sided p values. Ethical clearance for this observational cohort study was granted by the Comprehensive Community Based and Rehabilitation in Tanzania (CCBRT) hospital ethical committee.
ReSulTS
Fifty-two patients, 34 (65%) of whom were male, were enrolled in the study. In all patients, the operation on the phacoemulsification-only eye was undertaken after the PT eye. The phacoemulsification was undertaken a median of 125 days (first quartile 85, third quartile 233, range 26-902 days) after the PT. Baseline characteristics of the study group are shown in table 3.
Thirteen patients were taking topical medication prior to the surgery; in all instances this topical therapy had been taken for <6 months in total prior to the surgery. The mean preoperative spherical equivalent refractive error was −1.9 (range +2.5 to −7.25). All patients had gonioscopy at presentation and had wide open angles. Mean age at PT surgery was 70 years (SD 8 years) and three quarters of patients were aged 65 years or more. Preoperative VAs, IOPs and cup/disc (C/D) ratios were comparable in both eyes (PT 0.68 vs P 0.78, PT 31.8 vs P 30.4 and PT 0.81 vs P 0.79). Seven patients were on topical treatment at the time of last review. None were listed for further surgery.
Final versus preoperative IoP and VA
Restriction to those with 250 days or more follow-up in both eyes showed strong evidence (p=0.004) that both operations resulted in lower IOPs with an average 16.8 mm Hg or 50% (95%CI 45% to 55%) drop in IOP for PT and 12.9 mm Hg or 41% (95% CI 36% to 46%) drop for phaco alone. There was also evidence that both operations resulted in improved VAs in the region of 0.2 or more logMAR (p<0.001 for PT; p=0.03 for phacoemulsification).
Time periods of follow-up were paired for P and PT eyes for comparison. Nine individuals had two time periods with matched data. Tables 4 and 5 show the IOP and VA findings by period of follow-up for 61 paired time points. The overall average period of follow-up in the PT group was 512 days and in the phacoemulsification group 485 days. Apart from the very early follow-up period, the reduction in IOP was consistently greater in the PT group.
Change over time between follow-up points
In nine individuals with two paired time points, the rise in IOP between first (mean 337 days postoperatively) and second (mean 1482 days postoperatively) follow-up was 1.8 mm Hg in the PT eyes and 4.2 mm Hg in the phaco eyes (p=0.18). One individual had acuities of 0.5 logMAR in each eye at the first follow-up and acuities of 1.5 logMAR in the PT eye and perception of light in the phaco eye at second follow-up. The remainder had a mean acuity of 0.03 logMAR units worse in the PT eyes and 0.25 logMAR units worse in the phaco eyes at second follow-up. All phaco eyes had higher IOPs at later follow-up while four (44%) of the PT eyes had further lowering of the IOP. All phaco eyes had worse acuities at later follow-up while four (44%) of the PT eyes had further improved acuity. 
DISCuSSIon
This is the first study to report the effect of phacoemulsification on IOP control in African patients with POAG. We observed a much larger IOP reduction in Tanzanian patients for both procedures when compared with non-African populations reported elsewhere. [13] [14] [15] [16] [17] The reported IOP reduction after phacoemulsification in patients with POAG does not exceed 34% in other populations 15 while we report a 41% reduction (95% CI 36% to 46%). Proposed reasons for IOP reduction following cataract surgery include opening of the angle. Studies have shown that the anterior chamber angle opens in all eyes after cataract extraction. [18] [19] [20] Tia et al further noted in their study 19 that the angle widening depends on the patient's age with more angle widening in patients older than 60 years. They argue that this could be because of thicker lenses in older patients. It has been observed that after phacoemulsification the anterior chamber angle can widen and deepen by up to 50%. 20 The mean age of patients in our study was 70 years and more than 75% were at least 65 years old. Furthermore, cataract surgery results in chronic inflammation in the eye with flare in the anterior chamber persisting for up to 6 months following the procedure. Ciliary body or low-grade trabecular meshwork inflammation (as in selective laser trabeculoplasty) could also result in a lowering of IOP. 21 A South African study by Cook et al in 1998 demonstrated that there is an exaggerated inflammatory response in African patients postcataract surgery which can persist up to 6 months postoperatively. 22 Bhallil et al 23 suggest that possible mechanisms of IOP reduction after phacoemulsification may include (1) free radicals produced during surgery may act as inflammatory mediators; ciliary body irritation by the inflammatory mediators could result in hyposecretion of aqueous humour; (2) trabecular meshwork irrigation during surgery may decrease outflow resistance; (3) increase in surgically induced production of endogenous prostaglandins may augment uveoscleral outflow; and (4) phaco ultrasound stimulates production of interleukins 1α by trabecular meshwork thus increasing outflow facility and decreasing IOP.
This study addresses an important question for African populations in which most patients present very late when one eye is nearly lost from glaucoma and the other eye has advanced disease. 24 In this context, surgery is often the first line of treatment. Trabeculectomy only in African patients with co-existing cataract has an important drawback: pre-existing cataract tends to worsen, reducing vision so that within a short period of time further surgery is required to improve vision. This involves additional cost and inconvenience.
Combining the two operations in the form of PT is appealing as it addresses both the conditions. However, this is not a simple procedure. It requires surgeons trained in this procedure of whom there are relatively few in Africa. Moreover, PT has potential complications which may require further surgical interventions like bleb revision, bleb needling or sub-Tenon's 5FU injections. In addition, visual gain may be compromised by an initial exaggerated inflammatory response, hypotony and refractive errors. 25 26 Frequent follow-up is therefore desirable, but this may require the patient to remain close to the hospital, which may not be possible. In these circumstances, phacoemulsification surgery alone may be a better option because of the following: ► It is technically easier. ► Visual rehabilitation is faster. 
Clinical science
► There are fewer complications compared with the combined procedure ► A majority of the patients are elderly and their main concern for the remaining period of their lives is better vision for limited mobility around their surroundings. Phacoemulsification satisfies this requirement immediately postoperatively. ► Patients do not need close and frequent follow-up in comparison to trabeculectomy alone or combined with phacoemulsification. The question is whether cataract surgery alone can reduce IOP enough to slow the glaucomatous process and for how long? Our study indicates that although the IOP reduction following phacoemulsification may not be as marked as that achieved with PT, the effect did last for several years postoperatively.
A strength of this study is its within-individual design, which removes between individual variation as a source of uncertainty. However, the allocation of eyes within an individual to a particular procedure and the order of the procedures were not randomised. The eye with the better acuity was selected for PT which was performed before phacoemulsification. Nevertheless, there were not major preoperative differences between the eyes. The sample size of our study was small, particularly for long-term follow-up, and there may be important differences that this study was not powered to detect.
ConCluSIon
In this small study in African patients, PT resulted in lower IOPs than phacoemulsification alone but the difference between the procedures was relatively small. Phacoemulsification alone was effective in reducing IOP and improving VA for several years in this population. Given the relative simplicity of phacoemulsification, it is a therapeutic option worthy of consideration in some settings.
The challenges of therapy for this blinding disease in an African context are enormous. We are currently undertaking qualitative work to investigate patient attitudes to the disease and its therapy to further inform therapeutic strategies.
